CRABP1

Across TCGA pan-cancer cohorts, CRABP1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CRABP1 data layer compared with 26 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher CRABP1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated CRABP1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and PDAC show a favorable association.

CCRCC, UCEC, and PDAC are the cancer types where CRABP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Tertile	All	1.000	0.869	.010	24	view →
UCEC	DFS	Quartile	All	0.745	1.000	.001	20	view →
PDAC	OS	Tertile	II,III,IV	0.516	0.323	.019	4	view →
LSCC	DFS	Quartile	All	0.630	0.896	.013	3	view →
HNSC	OS	Tertile	IV	0.661	0.851	.039	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CRABP1–CCRCC (OS)

Open the CCRCC breakdown →